UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by Optivise Advisory Services LLC

Optivise Advisory Services LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 861 shares of the healthcare conglomerate’s stock after selling 28 shares during the period. Optivise Advisory Services LLC’s holdings in UnitedHealth Group were worth $436,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares during the last quarter. Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Waycross Partners LLC lifted its holdings in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the period. Czech National Bank lifted its stake in shares of UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after acquiring an additional 11,426 shares during the period. Finally, Lmcg Investments LLC increased its stake in shares of UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after acquiring an additional 4,022 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Mizuho lifted their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Truist Financial raised their price objective on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Twenty-one equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $632.85.

UnitedHealth Group Trading Down 22.0 %

NYSE UNH opened at $456.10 on Monday. The company has a market capitalization of $417.20 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $438.50 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $512.95 and its 200-day simple moving average is $539.93.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm earned $6.91 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.